- Are Vumerity and Ocrevus the Same Thing?
- What Are Possible Side Effects of Vumerity?
- What Are Possible Side Effects of Ocrevus?
- What Is Vumerity?
- What Is Ocrevus?
- What Drugs Interact with Vumerity?
- What Drugs Interact with Ocrevus?
- How Should Vumerity Be Taken?
- How Should Ocrevus Be Taken?
Are Vumerity and Ocrevus the Same Thing?
Vumerity (diroximel fumarate) and Ocrevus (ocrelizumab) are used to treat relapsing forms of multiple sclerosis (MS).
Ocrevus is also used to treat primary progressive forms of multiple sclerosis.
Vumerity and Ocrevus belong to different drug classes. Vumerity is an immunomodulator and Ocrevus is a CD20-directed cytolytic antibody.
Side effects of Vumerity that are different from Ocrevus include flushing, abdominal pain, diarrhea, nausea, vomiting, itching, rash, albumin in the urine, redness, and indigestion/heartburn.
Side effects of Ocrevus that are different from Vumerity include upper and lower respiratory tract infections, infusion reactions (itching, rash, hives, redness, bronchospasm, swollen and sore throat, mouth pain, shortness of breath, flushing, hypotension, fever, fatigue, headache, dizziness, nausea, and fast heart rate), skin infections, depression, back pain, and pain in the extremities.
Vumerity may interact with dimethyl fumarate.
Ocrevus may interact with other immune-modulating or immunosuppressive therapies, including immunosuppressant doses of corticosteroids.
What Are Possible Side Effects of Vumerity?
Common side effects of Vumerity include:
- abdominal pain,
- albumin in the urine,
- redness, and
What Are Possible Side Effects of Ocrevus?
Common side effects of Ocrevus include:
- upper respiratory tract infections,
- infusion reactions (itching, rash, hives, redness, bronchospasm, swollen and sore throat, mouth pain, shortness of breath, flushing, hypotension, fever, fatigue, headache, dizziness, nausea, and fast heart rate),
- skin infections,
- lower respiratory tract infections,
- back pain, and
- pain in the extremities.
What Is Vumerity?
Vumerity (diroximel fumarate) is an immunomodulator indicated for the treatment of relapsing forms of multiple sclerosis (MS), to include clinically isolated syndrome, relapsing-remitting disease, and active secondary progressive disease, in adults.
What Is Ocrevus?
Ocrevus (ocrelizumab) injection is aCD20-directed cytolytic antibody indicated for the treatment of patients with relapsing or primary progressive forms of multiple sclerosis.
What Drugs Interact With Vumerity?
Vumerity may interact with other medicines such as:
- dimethyl fumarate
Tell your doctor all medications and supplements you use.
What Drugs Interact With Ocrevus?
Hepatitis B virus screening is required before the first dose of Ocrevus. Pre-medicate with methylprednisolone (or an equivalent corticosteroid) and an antihistamine prior to each infusion. The starting dose of Ocrevus is 300 mg intravenous infusion, followed two weeks later by a second 300 mg intravenous infusion. Subsequent doses of Ocrevus are 600 mg intravenous infusion every 6 months.
How Should Vumerity Be Taken?
The starting dose of Vumerity is 231 mg twice a day, orally, for 7 days. The maintenance dose of Vumerity after 7 days is 462 mg (administered as two 231 mg capsules) twice a day, orally.
How Should Ocrevus Be Taken?
The recommended dosage of Ocrevus is 12 mg/day administered by intravenous infusion for 2 treatment courses: First Treatment Course: 12 mg/day on 5 consecutive days (60 mg total dose; Second Treatment Course: 12 mg/day on 3 consecutive days (36 mg total dose) administered 12 months after the first treatment course.
Health Solutions From Our Sponsors
All drug information provided on RxList.com is sourced directly from drug monographs published by the U.S. Food and Drug Administration (FDA).
Any drug information published on RxList.com regarding general drug information, drug side effects, drug usage, dosage, and more are sourced from the original drug documentation found in its FDA drug monograph.
Drug information found in the drug comparisons published on RxList.com is primarily sourced from the FDA drug information. The drug comparison information found in this article does not contain any data from clinical trials with human participants or animals performed by any of the drug manufacturers comparing the drugs.
The drug comparisons information provided does not cover every potential use, warning, drug interaction, side effect, or adverse or allergic reaction. RxList.com assumes no responsibility for any healthcare administered to a person based on the information found on this site.
As drug information can and will change at any time, RxList.com makes every effort to update its drug information. Due to the time-sensitive nature of drug information, RxList.com makes no guarantees that the information provided is the most current.
Any missing drug warnings or information does not in any way guarantee the safety, effectiveness, or the lack of adverse effects of any drug. The drug information provided is intended for reference only and should not be used as a substitute for medical advice.
If you have specific questions regarding a drug’s safety, side effects, usage, warnings, etc., you should contact your doctor or pharmacist, or refer to the individual drug monograph details found on the FDA.gov or RxList.com websites for more information.
You may also report negative side effects of prescription drugs to the FDA by visiting the FDA MedWatch website or calling 1-800-FDA-1088.
Genentech USA, Inc. Ocrevus Product Information.